Literature DB >> 2153065

Incidence and morbidity of cytomegaloviral infection in patients with mediastinitis following cardiac surgery.

Y Domart1, J L Trouillet, J Y Fagon, J Chastre, F Brun-Vezinet, C Gibert.   

Abstract

To determine the incidence and morbidity of infections with CMV associated with mediastinitis after conventional cardiac surgery, 115 consecutive adult patients with mediastinitis were evaluated with viral cultures of blood and urine. Shedding of CMV was seen in 29 patients (25 percent) within a mean period of 37 +/- 22 days after cardiopulmonary bypass. Viremia was documented in 79 percent (23) of these 29 patients. Acute renal failure and enzymatic abnormalities (AST and LDH) were significantly more common in patients with virologically proven infection with CMV (p less than 0.05). In patients who survived the initial period of bacterial infection, major differences in their clinical course were observed according to their virologic status. After the 15th day of hospitalization following the débridement, the persistence of local infection was more frequent (p less than 0.05) and the mortality was higher (p less than 0.01) in CMV-infected patients. Moreover, the mean duration of hospitalization in the ICU for survivors was 69 +/- 36 days in viral shedders, compared with 48 +/- 27 days in nonshedders (p less than 0.05). Infection with CMV in mediastinitis occurs frequently and is associated with persistence of local infection, prolonged hospitalization, and increased late mortality.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153065     DOI: 10.1378/chest.97.1.18

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  26 in total

Review 1.  Impact of cytomegalovirus load on host response to sepsis.

Authors:  Thomas Marandu; Michael Dombek; Charles H Cook
Journal:  Med Microbiol Immunol       Date:  2019-04-11       Impact factor: 3.402

2.  The pathogenetic role of CMV in intensive care unit patients: the uncertainity remains.

Authors:  Gerardo Aguilar; David Navarro
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

3.  Reactivation Viremia in Pediatric Sepsis.

Authors:  Moonjoo Han; Anna L Roberts; Brooke A Migliore; Ana María Cárdenas; Scott L Weiss
Journal:  Pediatr Crit Care Med       Date:  2020-04       Impact factor: 3.624

Review 4.  Resistant pathogens, fungi, and viruses.

Authors:  Christopher A Guidry; Sara A Mansfield; Robert G Sawyer; Charles H Cook
Journal:  Surg Clin North Am       Date:  2014-10-03       Impact factor: 2.741

Review 5.  CMV in critically ill patients: pathogen or bystander?

Authors:  Ajit P Limaye; Michael Boeckh
Journal:  Rev Med Virol       Date:  2010-11       Impact factor: 6.989

Review 6.  Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges.

Authors:  Charles H Cook; Joanne Trgovcich
Journal:  Antiviral Res       Date:  2011-03-23       Impact factor: 5.970

7.  Cytomegalovirus in the intensive care unit: pathogen or passenger?

Authors:  Jeffrey I Cohen
Journal:  Crit Care Med       Date:  2009-06       Impact factor: 7.598

8.  Cytomegalovirus reactivation in critically ill immunocompetent patients.

Authors:  Ajit P Limaye; Katharine A Kirby; Gordon D Rubenfeld; Wendy M Leisenring; Eileen M Bulger; Margaret J Neff; Nicole S Gibran; Meei-Li Huang; Tracy K Santo Hayes; Lawrence Corey; Michael Boeckh
Journal:  JAMA       Date:  2008-07-23       Impact factor: 56.272

9.  Broncholaveolar lavage to detect cytomegalovirus infection, latency, and reactivation in immune competent hosts.

Authors:  Sara Mansfield; Varun Dwivedi; Sara Byrd; Joanne Trgovcich; Marion Griessl; Michael Gutknecht; Charles H Cook
Journal:  J Med Virol       Date:  2016-02-02       Impact factor: 2.327

Review 10.  Cytomegalovirus infection in critically ill patients: a systematic review.

Authors:  Ryosuke Osawa; Nina Singh
Journal:  Crit Care       Date:  2009-05-14       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.